Clinical trial
Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases
NCT00309842 · Masonic Cancer Center, University of Minnesota, Other · Completed
Key facts
| NCT number | NCT00309842 |
|---|---|
| Title | Myeloablative Umbilical Cord Blood Transplantation in Hematological Diseases |
| Official title | Transplantation of Unrelated Umbilical Cord Blood for Patients With Hematological Diseases With Cyclophosphamide/Fludarabine/Total Body Irradiation Myeloablative Preparative Regimen |
| Lead sponsor | Masonic Cancer Center, University of Minnesota, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Acute Myeloid Leukemia, Acute Lymphocytic Leukemia, Chronic Myelogenous Leukemia, Myelofibrosis, MDS, Refractory Anemia, Chronic Lymphocytic Leukemia, Prolymphocytic Leukemia, Non-Hodgkin's Lymphoma, Leukemia and 3 more |
| Intervention type | Biological, Drug, Procedure, Radiation |
| Interventions | filgrastim, cyclophosphamide, cyclosporine, fludarabine phosphate, mycophenolate mofetil, umbilical cord blood transplantation, total-body irradiation |
| Enrollment | 213 |
| Start date | Jul 28, 2005 |
| Primary completion | Jul 29, 2019 |
| Completion | Nov 22, 2019 |
| First posted | Apr 3, 2006 |
| Last update posted | Sep 10, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: